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The Ovsynch protocol has been used in cattle to synchronize ovulation and facilitate fixed-time 
AI (FTAI) but its efficacy has not been evaluated in the Nigerian Muturu breed of B. indicus 
cattle. The effects of a modified Ovsynch protocol (modified by the addition of progesterone, 
eCG and modification of time for AI) upon the reproductive performance of Muturu cows were 
therefore studied.  
The study was  conducted at Abakiliki in Ebonyi state, Nigeria. Muturu cows (n=100) were 
selected for the study based on their previous calving history and the presence of follicle of 
greater than 5 mm diameter. Cows were then allotted to Untreated and Treated groups (n=50 
each).  Synchronization was by an Ovsynch regimen (Day 0: 100 μg GnRH, Day 7: 500 μg 
PGF2α (Ovuprost), Day 10: 100 μg GnRH), augmented by a progesterone-releasing 
intravaginal insert (CIDR) between Days 0 and 7, and 400 IU eCG (Norvomon) on Day 7. 
FTAI was performed 12 and 24 h after the second GnRH injection. Untreated animals were 
monitored over two consecutive oestrous cycles and examined daily for the presence of oestrus 
over a period of 49 days, and were exposed to natural mating upon detection of oestrus in the 
second oestrous cycle observed. Ovarian ultrasonography to ascertain follicle size was 
performed at the onset and end of oestrus in the Untreated group, and on Days 0,7,10 in the 
Treated group. Pregnancy diagnosis (ultrasonographic) was performed 45 days after FTAI 
(Synchronized) and 45 days after the last observed oestrus during the breeding season 
(Untreated). Blood samples were collected from Treated group of animals for progesterone, 
LH and oestradiol concentrations assay.  
All animals in the Treated group displayed oestrus after synchronization and all animals in the 
Untreated groups displayed oestrus during the 49-day study period.  Follicle size (18 ± 0.4 mm 
versus 12± 0.2 mm), ovulation rate (100% versus  64%), duration of oestrus (54 h versus 19 
h ) and 45-day pregnancy rate (84% versus 36%), were all greater (p<0.005) in Treated than 
Untreated animals. Additionally, the animals in the Treated group displayed 46% multiple 
ovulations, compared with none in the Untreated group. Oestradiol concentrations were related 
to follicle size. Increase in follicle size resulted in higher concentration of oestradiol. The 
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presence of multiple ovulations appears to have been related to the use of eCG in the protocol. 
No multiple pregnancies occurred.  
It is concluded that the modified Ovsynch protocol produced synchrony of oestrus, ovulation 
and improved follicle size, that were supported by normal endocrine patterns. It therefore 
appears that oestrus synchronization and FTAI can improve reproductive performance of the 
Muturu breed of cattle. 
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